Actively Recruiting
Evaluate the Results of Fall Prevention in Older Adults With Type 2 Diabetes Mellitus
Led by National Geriatric Hospital · Updated on 2024-11-13
80
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
.This randomized controlled clinical trial aims to evaluate the effects of fall prevention in older adults with type 2 diabetes mellitus. The main questions it aims to answer are: * Describe the current situation of falls, the risk of falls, and some related factors in elderly type 2 diabetic patients * Evaluate the results of fall prevention and related factors in the study population. Participants will be randomly divided into control and intervention groups. The intervention group will be trained to follow the Otago Training Program as the primary fall prevention method. On the other hand, the control group will receive the standard care following the treatment guidelines for type 2 diabetes mellitus and other comorbidities. At the end of the intervention, the study will mainly compare the rate of fall incidents after 6 months of intervention as well as other physical performance tests.
CONDITIONS
Official Title
Evaluate the Results of Fall Prevention in Older Adults With Type 2 Diabetes Mellitus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Type 2 diabetic patients diagnosed using American Diabetes Association 2022 criteria
- HbA1c between 7.0% and 9%
- Age between 60 and 80 years
- For the longitudinal study, moderate or high risk of falls according to World Guidelines for Falls Prevention and Management
- Recruitment from the cross-sectional study population
You will not qualify if you...
- Acute diabetic complications
- Acute phase of musculoskeletal disorders such as gout, progressing arthritis, joint pain, sciatic pain, or infectious arthritis
- Conditions significantly affecting cognition or mobility including stroke sequelae, muscular weakness, limb disabilities, severe heart failure, severe cognitive decline, or psychiatric disorders
- Bedridden for more than one month within the past three months
- Cardiovascular diseases including chest pain, uncontrolled blood pressure ≥160/100 mmHg, untreated cardiac arrhythmia, history of congestive heart failure, severe valvular heart disease, myocarditis or pericarditis, and hypertrophic cardiomyopathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Geriatric Hospital
Hanoi, Vietnam, 100000
Actively Recruiting
Research Team
H
Hoa T Dinh, MD
CONTACT
T
Tam N Nguyen, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here